Literature DB >> 23568522

The use of pseudo-equilibrium constant affords improved QSAR models of human plasma protein binding.

Xiang-Wei Zhu1, Alexander Sedykh, Hao Zhu, Shu-Shen Liu, Alexander Tropsha.   

Abstract

PURPOSE: To develop accurate in silico predictors of Plasma Protein Binding (PPB).
METHODS: Experimental PPB data were compiled for over 1,200 compounds. Two endpoints have been considered: (1) fraction bound (%PPB); and (2) the logarithm of a pseudo binding constant (lnKa) derived from %PPB. The latter metric was employed because it reflects the PPB thermodynamics and the distribution of the transformed data is closer to normal. Quantitative Structure-Activity Relationship (QSAR) models were built with Dragon descriptors and three statistical methods.
RESULTS: Five-fold external validation procedure resulted in models with the prediction accuracy (R²) of 0.67 ± 0.04 and 0.66 ± 0.04, respectively, and the mean absolute error (MAE) of 15.3 ± 0.2% and 13.6 ± 0.2%, respectively. Models were validated with two external datasets: 173 compounds from DrugBank, and 236 chemicals from the US EPA ToxCast project. Models built with lnKa were significantly more accurate (MAE of 6.2-10.7 %) than those built with %PPB (MAE of 11.9-17.6 %) for highly bound compounds both for the training and the external sets.
CONCLUSIONS: The pseudo binding constant (lnKa) is more appropriate for characterizing PPB binding than conventional %PPB. Validated QSAR models developed herein can be applied as reliable tools in early drug development and in chemical risk assessment.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23568522      PMCID: PMC4363124          DOI: 10.1007/s11095-013-1023-6

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  32 in total

1.  Novel variable selection quantitative structure--property relationship approach based on the k-nearest-neighbor principle

Authors: 
Journal:  J Chem Inf Comput Sci       Date:  2000-01

2.  Predicting plasma protein binding of drugs: a new approach.

Authors:  Nicole A Kratochwil; Walter Huber; Francis Müller; Manfred Kansy; Paul R Gerber
Journal:  Biochem Pharmacol       Date:  2002-11-01       Impact factor: 5.858

3.  In silico prediction of aqueous solubility, human plasma protein binding and volume of distribution of compounds from calculated pKa and AlogP98 values.

Authors:  Mario Lobell; Vinothini Sivarajah
Journal:  Mol Divers       Date:  2003       Impact factor: 2.943

4.  Random forest: a classification and regression tool for compound classification and QSAR modeling.

Authors:  Vladimir Svetnik; Andy Liaw; Christopher Tong; J Christopher Culberson; Robert P Sheridan; Bradley P Feuston
Journal:  J Chem Inf Comput Sci       Date:  2003 Nov-Dec

5.  Rational selection of training and test sets for the development of validated QSAR models.

Authors:  Alexander Golbraikh; Min Shen; Zhiyan Xiao; Yun-De Xiao; Kuo-Hsiung Lee; Alexander Tropsha
Journal:  J Comput Aided Mol Des       Date:  2003 Feb-Apr       Impact factor: 3.686

6.  Computational prediction of the plasma protein-binding percent of diverse pharmaceutical compounds.

Authors:  Kazuto Yamazaki; Masaharu Kanaoka
Journal:  J Pharm Sci       Date:  2004-06       Impact factor: 3.534

7.  Distribution of biotin in human plasma: most of the biotin is not bound to protein.

Authors:  D M Mock; M I Malik
Journal:  Am J Clin Nutr       Date:  1992-08       Impact factor: 7.045

8.  On outliers and activity cliffs--why QSAR often disappoints.

Authors:  Gerald M Maggiora
Journal:  J Chem Inf Model       Date:  2006 Jul-Aug       Impact factor: 4.956

9.  The impact of plasma protein binding on the renal transport of organic anions.

Authors:  Daniel A J Bow; Jennifer L Perry; John D Simon; John B Pritchard
Journal:  J Pharmacol Exp Ther       Date:  2005-09-29       Impact factor: 4.030

10.  QSAR modeling of beta-lactam binding to human serum proteins.

Authors:  L Mark Hall; Lowell H Hall; Lemont B Kier
Journal:  J Comput Aided Mol Des       Date:  2003 Feb-Apr       Impact factor: 3.686

View more
  10 in total

1.  Chembench: A Publicly Accessible, Integrated Cheminformatics Portal.

Authors:  Stephen J Capuzzi; Ian Sang-June Kim; Wai In Lam; Thomas E Thornton; Eugene N Muratov; Diane Pozefsky; Alexander Tropsha
Journal:  J Chem Inf Model       Date:  2017-01-19       Impact factor: 4.956

Review 2.  An updated review on drug-induced cholestasis: mechanisms and investigation of physicochemical properties and pharmacokinetic parameters.

Authors:  Kyunghee Yang; Kathleen Köck; Alexander Sedykh; Alexander Tropsha; Kim L R Brouwer
Journal:  J Pharm Sci       Date:  2013-05-07       Impact factor: 3.534

Review 3.  In vitro to in vivo extrapolation for high throughput prioritization and decision making.

Authors:  Shannon M Bell; Xiaoqing Chang; John F Wambaugh; David G Allen; Mike Bartels; Kim L R Brouwer; Warren M Casey; Neepa Choksi; Stephen S Ferguson; Grazyna Fraczkiewicz; Annie M Jarabek; Alice Ke; Annie Lumen; Scott G Lynn; Alicia Paini; Paul S Price; Caroline Ring; Ted W Simon; Nisha S Sipes; Catherine S Sprankle; Judy Strickland; John Troutman; Barbara A Wetmore; Nicole C Kleinstreuer
Journal:  Toxicol In Vitro       Date:  2017-12-05       Impact factor: 3.500

4.  Rapid experimental measurements of physicochemical properties to inform models and testing.

Authors:  Chantel I Nicolas; Kamel Mansouri; Katherine A Phillips; Christopher M Grulke; Ann M Richard; Antony J Williams; James Rabinowitz; Kristin K Isaacs; Alice Yau; John F Wambaugh
Journal:  Sci Total Environ       Date:  2018-05-02       Impact factor: 7.963

5.  Evaluation and calibration of high-throughput predictions of chemical distribution to tissues.

Authors:  Robert G Pearce; R Woodrow Setzer; Jimena L Davis; John F Wambaugh
Journal:  J Pharmacokinet Pharmacodyn       Date:  2017-10-14       Impact factor: 2.745

6.  Towards best use and regulatory acceptance of generic physiologically based kinetic (PBK) models for in vitro-to-in vivo extrapolation (IVIVE) in chemical risk assessment.

Authors:  Abdulkarim Najjar; Ans Punt; John Wambaugh; Alicia Paini; Corie Ellison; Styliani Fragki; Enrica Bianchi; Fagen Zhang; Joost Westerhout; Dennis Mueller; Hequn Li; Quan Shi; Timothy W Gant; Phil Botham; Rémi Bars; Aldert Piersma; Ben van Ravenzwaay; Nynke I Kramer
Journal:  Arch Toxicol       Date:  2022-09-05       Impact factor: 6.168

7.  Designing QSARs for Parameters of High-Throughput Toxicokinetic Models Using Open-Source Descriptors.

Authors:  Daniel E Dawson; Brandall L Ingle; Katherine A Phillips; John W Nichols; John F Wambaugh; Rogelio Tornero-Velez
Journal:  Environ Sci Technol       Date:  2021-04-15       Impact factor: 9.028

8.  Evaluation of Quantitative Structure Property Relationship Algorithms for Predicting Plasma Protein Binding in Humans.

Authors:  Yejin Esther Yun; Rogelio Tornero-Velez; S Thomas Purucker; Daniel T Chang; Andrea N Edginton
Journal:  Comput Toxicol       Date:  2021-02-01

9.  Computer-Aided Drug Design Applied to Marine Drug Discovery: Meridianins as Alzheimer's Disease Therapeutic Agents.

Authors:  Laura Llorach-Pares; Alfons Nonell-Canals; Melchor Sanchez-Martinez; Conxita Avila
Journal:  Mar Drugs       Date:  2017-11-27       Impact factor: 5.118

10.  Plasma protein binding prediction focusing on residue-level features and circularity of cyclic peptides by deep learning.

Authors:  Jianan Li; Keisuke Yanagisawa; Yasushi Yoshikawa; Masahito Ohue; Yutaka Akiyama
Journal:  Bioinformatics       Date:  2021-11-22       Impact factor: 6.937

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.